Skip to content
← Lobby register
NN
Other

Novo Nordisk A/S

🇪🇺 DENMARKRegistered 13/016 staff
Disclosed budget
€2,000,000 — €2,249,999
Meetings 12mo
24
Policy files
2
Accredited passes
1

Recent meetings

DateCommissioner / CabinetTopicFile
20 Feb 2026
Dan Jørgensen
Commissioner
European competitiveness and the Biotech ActSRC
20 Feb 2026
Dan Jørgensen
Commissioner
European competitiveness and the Biotech Act
21 Jan 2026
Ekaterina Zaharieva
Commissioner
Maintaining momentum and support for the Scaleup Europe Fund
21 Jan 2026
Roxana Mînzatu
Executive Vice-President
Skills development, quality jobsSRC
21 Jan 2026
Ekaterina Zaharieva
Commissioner
Maintaining momentum and support for the Scaleup Europe FundSRC
21 Jan 2026
Annukka Ojala
Cabinet member
Skills development, quality jobs
21 Jan 2026
Annukka Ojala
Cabinet member
Skills development, quality jobsSRC
21 Jan 2026
Andreas Schwarz
Cabinet member
Maintaining momentum and support for the Scaleup Europe FundSRC
21 Jan 2026
Andreas Schwarz
Cabinet member
Maintaining momentum and support for the Scaleup Europe Fund
21 Jan 2026
Roxana Mînzatu
Executive Vice-President
Skills development, quality jobs
03 Dec 2025
Matthias Jorgensen
Acting Director
Exchange of views on EU-US Trade Relations.
03 Dec 2025
Matthias Jorgensen
Acting Director
Exchange of views on EU-US Trade Relations.SRC
02 Oct 2025
Lucilla Sioli
Director
AI in life sciences
02 Oct 2025
Saila Rinne
Head of Unit
AI in life sciences
02 Oct 2025
Saila Rinne
Head of Unit
AI in life sciencesSRC
02 Oct 2025
Lucilla Sioli
Director
AI in life sciencesSRC
30 Sept 2025
Elena Martines
Cabinet member
Exchange on the Scaleup Europe FundSRC
30 Sept 2025
Elena Martines
Cabinet member
Exchange on the Scaleup Europe Fund
05 Sept 2025
Elena Martines
Cabinet member
scaleup financing of European deeptech startups
05 Sept 2025
Elena Martines
Cabinet member
scaleup financing of European deeptech startupsSRC
25 Jun 2025
Andreas Schwarz
Cabinet member
Exchange on the structure and outreach of the Scaleup Europe Fund.SRC
25 Jun 2025
Andreas Schwarz
Cabinet member
Exchange on the structure and outreach of the Scaleup Europe Fund.
25 Jun 2025
Sven Gentner
Head of Unit
Reporting challenges for holding and investment companies under the CSRD
25 Jun 2025
Sven Gentner
Head of Unit
Reporting challenges for holding and investment companies under the CSRDSRC
30 Apr 2025
Vilija Sysaite
Cabinet member
Pharma industry and potential visit to premises in DK

Mission & Goals

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to serious chronic diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure the diseases we treat. We employ more than 60,000 people in 80 countries, and market our products in 170 countries. In 2023, we served more than 40 million patients worldwide. In 2023, we served more than 6 million patients in the EU. More than 30,000 of our employees are based in the EU. Novo Nordisk is committed to developing its business towards environmental, social and financial sustainability (the triple bottom line).The controlling stake in Novo Nordisk is owned by the Novo Nordisk Foundation. This is a non-profit institution, whose formal purpose is to provide a stable basis for its companies’ operations and to make contributions to scientific, humanitarian and social progress.

EU Legislative Interests

EU pharmaceutical-related policy, as well as broader health, environmental and business-related policy.

Communication Activities

The LinkedIn account of our CEO, Mike Maziar Doustdar, may sometimes include content relevant to activities covered by the Register. Other executive communications sometimes also reference EU policy.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

Novo Nordisk is a member of: - EFPIA - The Danish Chamber of Commerce - The Confederation of Danish Industries - EUCOPE - Science|Business

Organisation Members

n/a

Connected Legislation